Detection and characterization of a type IIA secretory phospholipase A2 inhibitory protein in human amniotic fluid

被引:0
|
作者
Moon, TC
Lee, JH
Lee, SH
Park, YK
Baek, SH
Chang, HW [1 ]
机构
[1] Yeungnam Univ, Coll Pharm, Kyongsan 712749, South Korea
[2] Yeungnam Univ, Coll Med, Taegu 715717, South Korea
关键词
type IIA sPLA(2) inhibitory protein; human amniotic fluid; parturition;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
lTwo types of phospholipase A, (PLA,) inhibitory protein (PLIP-I, PLIP-II) were detected and isolated from human amniotic fluid by Sephacryl S300 gel filtration chromatography: The lower molecular weight-fraction (FLIP-II) was further purified by Sephadex G75 gel filtration and analyzed by SDS-PAGE, Its molecular weight was estimated to be approximately 18 kDa, and it was sensitive to heat treatment. Inhibition of phospholipase A(2) (sPLA(2) type IIA) by PLIP-II occurred in a dose-dependent manner (IC50 about 0.82 mu M), and the effect was stronger on sPLA(2) IIA than on pancreatic sPLA(2) (IC50 about 3.11 mu M). The ratio of the inhibitions of the sPLA(2) IIA by FLIP-II remained consistent over an entire range of substrate concentrations. Furthermore, addition of excess Ca2+ at concentrations of up to 10 mM did not antagonize the inhibitory activity of PLIP-II.
引用
收藏
页码:1163 / 1166
页数:4
相关论文
共 50 条
  • [31] Characterization of a secretory phospholipase A(2) in human bronchoalveolar lavage fluid
    Samet, JM
    Madden, MC
    Fonteh, AN
    EXPERIMENTAL LUNG RESEARCH, 1996, 22 (03) : 299 - 315
  • [32] Effects of LDL Lipids on Activity of Group IIA Secretory Phospholipase A2
    E. V. Samoilova
    A. A. Pirkova
    N. V. Prokazova
    A. A. Korotaeva
    Bulletin of Experimental Biology and Medicine, 2010, 150 : 39 - 41
  • [33] Total direct chemical synthesis and biological activities of human group IIA secretory phospholipase A2
    Dong, CZ
    Romieu, A
    Mounier, CM
    Heymans, F
    Roques, BP
    Godfroid, JJ
    BIOCHEMICAL JOURNAL, 2002, 365 : 505 - 511
  • [34] Enhancement of leukocyte response to lipopolysaccharide by secretory group IIA phospholipase A2
    Cai, TQ
    Thieblemont, N
    Wong, B
    Thieringer, R
    Kennedy, BP
    Wright, SD
    FASEB JOURNAL, 1999, 13 (04): : A310 - A310
  • [35] Enhancement of leukocyte response to lipopolysaccharide by secretory group IIA phospholipase A2
    Cai, TQ
    Thieblemont, N
    Wong, BM
    Thieringer, R
    Kennedy, BP
    Wright, SD
    JOURNAL OF LEUKOCYTE BIOLOGY, 1999, 65 (06) : 750 - 756
  • [36] Effects of LDL Lipids on Activity of Group IIA Secretory Phospholipase A2
    Samoilova, E. V.
    Pirkova, A. A.
    Prokazova, N. V.
    Korotaeva, A. A.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2010, 150 (01) : 39 - 41
  • [37] Secretory phospholipase A2 group IIA modulates insulin sensitivity and metabolism
    Kuefner, Michael S.
    Pham, Kevin
    Redd, Jeanna R.
    Stephenson, Erin J.
    Harvey, Innocence
    Deng, Xiong
    Bridges, Dave
    Boilard, Eric
    Elam, Marshall B.
    Park, Edwards A.
    JOURNAL OF LIPID RESEARCH, 2017, 58 (09) : 1822 - 1833
  • [38] Biological effects of secretory phospholipase A2 group IIA on lipoproteins and in atherogenesis
    Jaross, W
    Eckey, R
    Menschikowski, M
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2002, 32 (06) : 383 - 393
  • [39] Halogenated phospholipids regulate secretory phospholipase A2 group IIA activity
    Korotaeva, Aleksandra
    Samoilova, Elena
    Pavlunina, Tatyana
    Panasenko, Oleg M.
    CHEMISTRY AND PHYSICS OF LIPIDS, 2013, 167 : 51 - 56
  • [40] Human group IIA secretory phospholipase A2 induces neuronal cell death via apoptosis
    Yagami, T
    Ueda, K
    Asakura, K
    Hata, S
    Kuroda, T
    Sakaeda, T
    Takasu, N
    Tanaka, K
    Gemba, T
    Hori, Y
    MOLECULAR PHARMACOLOGY, 2002, 61 (01) : 114 - 126